A phase 1 study of oral ASP5878, a selective small-molecule inhibitor of fibroblast growth factor receptors 1–4, as a single dose and multiple doses in patients with solid malignancies
Yamamoto, Noboru, Ryoo, Baek-Yeol, Keam, Bhumsuk, Kudo, Masatoshi, Lin, Chia-Chi, Kunieda, Futoshi, Ball, Howard A., Moran, Diarmuid, Komatsu, Kanji, Takeda, Kentaro, Fukuda, Musashi, Furuse, Junji, MJournal:
Investigational New Drugs
DOI:
10.1007/s10637-019-00780-w
Date:
April, 2019
File:
PDF, 655 KB
2019
File converter
More search results
More benefits 
